Section Arrow
Quote
BNTX.NASDAQ
- BioNTech SE American Depositary Share
Quotes are at least 15-min delayed:2024/05/16 16:55 EDT
Last
 92.98
+0.78 (+0.85%)
Day High 
93.3 
Prev. Close
92.2 
1-M High
95.29 
Volume 
389.08K 
Bid
92.9
Ask
93
Day Low
91.78 
Open
92 
1-M Low
85.4 
Market Cap 
22.22B 
Currency USD 
P/E 180.18 
%Yield 2.29 
10-SMA 92.03 
20-SMA 89.92 
50-SMA 90.65 
52-W High 125.83 
52-W Low 85.2129 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.47/-3.13
Enterprise Value
22.41B
Balance Sheet
Book Value Per Share
89.24
Cash Flow
Cash Flow Yield
0.28
Income Statement
Total Revenue
17.31B
Operating Revenue Per Share
29.07
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.1001+0.0224+28.83%-- 
DNAGinkgo Bioworks Holdings0.839-0.0001-0.01%-- 
NBYNovaBay Pharmaceuticals0.12+0.0155+14.83%-- 
JAGXJaguar Health0.2867+0.0316+12.39%-- 
NVAXNovavax14.4+1.5+11.63%-- 
Quotes are at least 15-min delayed：2024/05/16 16:55 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates. BioNTech is partnered with several large pharmaceuticalcompanies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.